The National Health Service (NHS) in England recently released two studies that provide the first information available about risks of COVID-19 in peo...Read More
JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
TORONTO – October 20, 2016, JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia – a common, potentially life-threatening, risk for people living with type 1 diabet...
JDRF and the University of Toronto are supporting research that will help improve islet transplantation and make the procedure more widely available for patients living with type 1 diabetes (T1D).
JDRF Canada awards $466,450 (USD) to Dr. Ahmad Haidar and his team at McGill University to improve the artificial pancreas system
JDRF Canada awards new research grant to Dr. Kieffer to explore new options for stem cell derived transplants for diabetes patients
JDRF Canada has made a major investment in accelerating type 1 diabetes research by awarding over $4M USD in grants to researchers across Canada.
JDRF will contribute up to $500,000 in funds to finance preclinical studies on the MAILPAN® bioartificial pancreas
Sernova and JDRF Announce Funding of Joint Research Collaboration to Advance Human Clinical Trials for the Treatment of Hypoglycemic Unawareness Patients with Severe Type 1 Diabetes
$2.45 million USD awarded to advance Sernova’s Cell Pouch System(TM) (CPS) technologies in a US FDA Clinical Trial with Initiation Scheduled for the Second Half of 2016
JDRF presented three prestigious research awards to three experts whose groundbreaking research is accelerating life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications.